908 Devices

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

MASS

Analyst Color

Large Cap

News

Health Care

Analyst Ratings

Movers

Trading Ideas

General

RGEN

Repligen acquires 908 Devices&#39; desktop portfolio for $70 million, enhancing its bioprocessing analytics. 908 Devices shifts focus to handheld growth, forecasting revenue gains.

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

movers image

APLD

AZTR

CRKN

CVGW

GCTK

GLAC

HSDT

LFWD

ORKA

QBTS

QUBT

RIME

SGBX

VMAR

VRME

Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket

xr:d:DAFyw9W8_jU:2,j:4019870324297586696,t:23103019

Long Ideas

Insider Trades

Pre-Market Outlook

Markets

HTLD

$2.8M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying

908 Devices Inc

Massnet

MASSIVIT 3D PRTG TECH LTD by MASSIVIT 3D PRTG TECHNOLOGIES LTD

MASSMART HOLDINGS LTD by Massmart Holdings Ltd.

MASS MEGAWATTS WIND PWR by Mass Megawatts Wind Power, Inc.

Mass Megawatts Wind Power Inc

MASSACHUSETTS BUS DEV CRP by Massachusetts Business Development Corp.

Massachusetts Business Development Corp

MASSACHUSETTS ELEC 4.44PR by Massachusetts Electric Co.

Massachusetts Electric Co

Massimo Group

Press Releases

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Contracts

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

Aeva Technologies

Coda Octopus Group

Evolv Technologies Holdings, Inc. - Class A Common Stock

Evolv Technologies

Faro Technologies

Focus Universal

Frequency Electronics, Inc. - Common Stock

Frequency Electronics

Identiv

nLight

Interlink Electronics, Inc. - Common Stock

Interlink Electronics

LightPath Technologies, Inc. - Class A Common Stock

LightPath Technologies

MultiSensor AI Holdings, Inc. - Common Stock

MultiSensor AI Holdings

Microvision

NOVONIX Limited - American Depository Shares

NOVONIX

Ouster

Red Cat Hldgs

Research Frontiers Incorporated - Common Stock

Research Frontiers

SmartRent

Sono-Tek

ScanTech AI Systems

TROOPS

Unusual Machines

Vishay Precision Group, Inc. Common Stock

Vishay Precision Group

Vuzix

Wrap Technologies

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares

Comments

908 Devices

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga